# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-288164
Filing Date
2025-11-19
Accepted
2025-11-19 16:30:32
Documents
18
Period of Report
2025-12-19

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | rkda-20251119.htm iXBRL | DEF 14A | 1224529
2 | GRAPHIC | img71583808_0.jpg | GRAPHIC | 29171
3 | GRAPHIC | img71583808_1.jpg | GRAPHIC | 75167
4 | GRAPHIC | img71583808_2.jpg | GRAPHIC | 78944
5 | GRAPHIC | img71583808_3.jpg | GRAPHIC | 73308
6 | GRAPHIC | img71583808_4.jpg | GRAPHIC | 102203
| Complete submission text file | 0001193125-25-288164.txt |  | 3023367

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | rkda-20251119.xsd | EX-101.SCH | 17086
20 | EXTRACTED XBRL INSTANCE DOCUMENT | rkda-20251119_htm.xml | XML | 294626

Mailing Address 5956 SHERRY LANE SUITE 2000 DALLAS TX
Business Address 5956 SHERRY LANE SUITE 2000 DALLAS TX 214-974-8921
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37383 | Film No.: 251499728
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)